Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in ...

The global weight management market is poised for significant growth over the next decade, driven by increasing awareness of ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...